智通财经APP讯,医汇集团(08161)发布截至2025年9月30日止六个月业绩,收益4337.6万港元,同比下降25.1%;公司拥有人应占亏损3万港元,同比收窄96.7%;每股基本亏损0.074港仙。
期内业绩改善主要由于2025年2月完成出售公司产生亏损的附属公司恒泉有限公司,以致集团于本期间的营运亏损减少;及本期间实施有效的成本控制措施。
智通财经APP讯,医汇集团(08161)发布截至2025年9月30日止六个月业绩,收益4337.6万港元,同比下降25.1%;公司拥有人应占亏损3万港元,同比收窄96.7%;每股基本亏损0.074港仙。
期内业绩改善主要由于2025年2月完成出售公司产生亏损的附属公司恒泉有限公司,以致集团于本期间的营运亏损减少;及本期间实施有效的成本控制措施。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.